Global Opioid Induced Constipation (OIC) Drug Market Insights, Forecast to 2025

Publisher Name :
Date: 19-Oct-2018
No. of pages: 125
Inquire Before Buying

Opioid-induced constipation (OIC) is a common adverse effect experienced by many patients on opioid therapy for chronic pain. OTC medications include stimulant laxatives, stool softeners, and enemas.

In 2017, the global Opioid Induced Constipation (OIC) Drug market size was xx million US$ and is forecast to xx million US in 2025, growing at a CAGR of xx% from 2018. The objectives of this study are to define, segment, and project the size of the Opioid Induced Constipation (OIC) Drug market based on company, product type, application and key regions.

This report studies the global market size of Opioid Induced Constipation (OIC) Drug in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Opioid Induced Constipation (OIC) Drug in these regions.

This research report categorizes the global Opioid Induced Constipation (OIC) Drug market by players/brands, region, type and application. This report also studies the global market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels, distributors and Porter's Five Forces Analysis.

The various contributors involved in the value chain of Opioid Induced Constipation (OIC) Drug include manufacturers, suppliers, distributors, intermediaries, and customers. The key manufacturers in the Opioid Induced Constipation (OIC) Drug include

- Ironwood Pharmaceuticals

- Daiichi Sankyo Co

- Pfizer

- Progenics Pharmaceuticals

- Shionogi &

- Allergan

- Nektar Therapeutics

- Purdue Pharma

- S.L.A. Pharma

- Mundipharma International Limited

- Ono Pharmaceutical

- Takeda Pharmaceutical Company Limited

- Theravance Biopharma

- Valeant Pharmaceuticals International

- Cosmo Pharmaceuticals SA

- Daewoong Pharmaceutical

- C.B. Fleet Company

- Sucampo Pharmaceuticals

Market Size Split by Type

- Lubiprostone

- Methyl Naltrexone Bromide

- Naldemedine

- Alvimopan

- Other

Market Size Split by Application

- Hospital Pharmacies

- Retail Pharmacies

- Online Pharmacies

Market size split by Region

- North America

- - United States

- - Canada

- - Mexico

- Asia-Pacific

- - China

- - India

- - Japan

- - South Korea

- - Australia

- - Indonesia

- - Singapore

- - Malaysia

- - Philippines

- - Thailand

- - Vietnam

- Europe

- - Germany

- - France

- - UK

- - Italy

- - Spain

- - Russia

- Central & South America

- - Brazil

- - Rest of Central & South America

- Middle East & Africa

- - GCC Countries

- - Turkey

- - Egypt

- - South Africa

The study objectives of this report are:

- To study and analyze the global Opioid Induced Constipation (OIC) Drug market size (value & volume) by company, key regions/countries, products and application, history data from 2013 to 2017, and forecast to 2025.

- To understand the structure of Opioid Induced Constipation (OIC) Drug market by identifying its various subsegments.

- To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).

- Focuses on the key global Opioid Induced Constipation (OIC) Drug manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.

- To analyze the Opioid Induced Constipation (OIC) Drug with respect to individual growth trends, future prospects, and their contribution to the total market.

- To project the value and volume of Opioid Induced Constipation (OIC) Drug submarkets, with respect to key regions (along with their respective key countries).

- To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

- To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Opioid Induced Constipation (OIC) Drug are as follows:

- History Year: 2013-2017

- Base Year: 2017

- Estimated Year: 2018

- Forecast Year 2018 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Opioid Induced Constipation (OIC) Drug market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Global Opioid Induced Constipation (OIC) Drug Market Insights, Forecast to 2025

Table of Contents
1 Study Coverage
1.1 Opioid Induced Constipation (OIC) Drug Product
1.2 Key Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Opioid Induced Constipation (OIC) Drug Market Size Growth Rate by Type
1.4.2 Lubiprostone
1.4.3 Methyl Naltrexone Bromide
1.4.4 Naldemedine
1.4.5 Alvimopan
1.4.6 Other
1.5 Market by Application
1.5.1 Global Opioid Induced Constipation (OIC) Drug Market Size Growth Rate by Application
1.5.2 Hospital Pharmacies
1.5.3 Retail Pharmacies
1.5.4 Online Pharmacies
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Opioid Induced Constipation (OIC) Drug Market Size
2.1.1 Global Opioid Induced Constipation (OIC) Drug Revenue 2016-2025
2.1.2 Global Opioid Induced Constipation (OIC) Drug Sales 2016-2025
2.2 Opioid Induced Constipation (OIC) Drug Growth Rate by Regions
2.2.1 Global Opioid Induced Constipation (OIC) Drug Sales by Regions
2.2.2 Global Opioid Induced Constipation (OIC) Drug Revenue by Regions
3 Breakdown Data by Manufacturers
3.1 Opioid Induced Constipation (OIC) Drug Sales by Manufacturers
3.1.1 Opioid Induced Constipation (OIC) Drug Sales by Manufacturers
3.1.2 Opioid Induced Constipation (OIC) Drug Sales Market Share by Manufacturers
3.1.3 Global Opioid Induced Constipation (OIC) Drug Market Concentration Ratio (CR5 and HHI)
3.2 Opioid Induced Constipation (OIC) Drug Revenue by Manufacturers
3.2.1 Opioid Induced Constipation (OIC) Drug Revenue by Manufacturers (2016-2018)
3.2.2 Opioid Induced Constipation (OIC) Drug Revenue Share by Manufacturers (2016-2018)
3.3 Opioid Induced Constipation (OIC) Drug Price by Manufacturers
3.4 Opioid Induced Constipation (OIC) Drug Manufacturing Base Distribution, Product Types
3.4.1 Opioid Induced Constipation (OIC) Drug Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Opioid Induced Constipation (OIC) Drug Product Category
3.4.3 Date of International Manufacturers Enter into Opioid Induced Constipation (OIC) Drug Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type
4.1 Global Opioid Induced Constipation (OIC) Drug Sales by Type
4.2 Global Opioid Induced Constipation (OIC) Drug Revenue by Type
4.3 Opioid Induced Constipation (OIC) Drug Price by Type
5 Breakdown Data by Application
5.1 Overview
5.2 Global Opioid Induced Constipation (OIC) Drug Breakdown Data by Application
6 North America
6.1 North America Opioid Induced Constipation (OIC) Drug by Countries
6.1.1 North America Opioid Induced Constipation (OIC) Drug Sales by Countries
6.1.2 North America Opioid Induced Constipation (OIC) Drug Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Opioid Induced Constipation (OIC) Drug by Type
6.3 North America Opioid Induced Constipation (OIC) Drug by Application
6.4 North America Opioid Induced Constipation (OIC) Drug by Company
7 Europe
7.1 Europe Opioid Induced Constipation (OIC) Drug by Countries
7.1.1 Europe Opioid Induced Constipation (OIC) Drug Sales by Countries
7.1.2 Europe Opioid Induced Constipation (OIC) Drug Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Opioid Induced Constipation (OIC) Drug by Type
7.3 Europe Opioid Induced Constipation (OIC) Drug by Application
7.4 Europe Opioid Induced Constipation (OIC) Drug by Company
8 Asia Pacific
8.1 Asia Pacific Opioid Induced Constipation (OIC) Drug by Countries
8.1.1 Asia Pacific Opioid Induced Constipation (OIC) Drug Sales by Countries
8.1.2 Asia Pacific Opioid Induced Constipation (OIC) Drug Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Opioid Induced Constipation (OIC) Drug by Type
8.3 Asia Pacific Opioid Induced Constipation (OIC) Drug by Application
8.4 Asia Pacific Opioid Induced Constipation (OIC) Drug by Company
9 Central & South America
9.1 Central & South America Opioid Induced Constipation (OIC) Drug by Countries
9.1.1 Central & South America Opioid Induced Constipation (OIC) Drug Sales by Countries
9.1.2 Central & South America Opioid Induced Constipation (OIC) Drug Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Opioid Induced Constipation (OIC) Drug by Type
9.3 Central & South America Opioid Induced Constipation (OIC) Drug by Application
9.4 Central & South America Opioid Induced Constipation (OIC) Drug by Company
10 Middle East and Africa
10.1 Middle East and Africa Opioid Induced Constipation (OIC) Drug by Countries
10.1.1 Middle East and Africa Opioid Induced Constipation (OIC) Drug Sales by Countries
10.1.2 Middle East and Africa Opioid Induced Constipation (OIC) Drug Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Opioid Induced Constipation (OIC) Drug by Type
10.3 Middle East and Africa Opioid Induced Constipation (OIC) Drug by Application
10.4 Middle East and Africa Opioid Induced Constipation (OIC) Drug by Company
11 Company Profiles
11.1 Ironwood Pharmaceuticals
11.1.1 Ironwood Pharmaceuticals Company Details
11.1.2 Company Description
11.1.3 Sales, Revenue and Gross Margin of Opioid Induced Constipation (OIC) Drug
11.1.4 Opioid Induced Constipation (OIC) Drug Product Description
11.1.5 Recent Development
11.2 Daiichi Sankyo Co
11.2.1 Daiichi Sankyo Co Company Details
11.2.2 Company Description
11.2.3 Sales, Revenue and Gross Margin of Opioid Induced Constipation (OIC) Drug
11.2.4 Opioid Induced Constipation (OIC) Drug Product Description
11.2.5 Recent Development
11.3 Pfizer
11.3.1 Pfizer Company Details
11.3.2 Company Description
11.3.3 Sales, Revenue and Gross Margin of Opioid Induced Constipation (OIC) Drug
11.3.4 Opioid Induced Constipation (OIC) Drug Product Description
11.3.5 Recent Development
11.4 Progenics Pharmaceuticals
11.4.1 Progenics Pharmaceuticals Company Details
11.4.2 Company Description
11.4.3 Sales, Revenue and Gross Margin of Opioid Induced Constipation (OIC) Drug
11.4.4 Opioid Induced Constipation (OIC) Drug Product Description
11.4.5 Recent Development
11.5 Shionogi &
11.5.1 Shionogi & Company Details
11.5.2 Company Description
11.5.3 Sales, Revenue and Gross Margin of Opioid Induced Constipation (OIC) Drug
11.5.4 Opioid Induced Constipation (OIC) Drug Product Description
11.5.5 Recent Development
11.6 Allergan
11.6.1 Allergan Company Details
11.6.2 Company Description
11.6.3 Sales, Revenue and Gross Margin of Opioid Induced Constipation (OIC) Drug
11.6.4 Opioid Induced Constipation (OIC) Drug Product Description
11.6.5 Recent Development
11.7 Nektar Therapeutics
11.7.1 Nektar Therapeutics Company Details
11.7.2 Company Description
11.7.3 Sales, Revenue and Gross Margin of Opioid Induced Constipation (OIC) Drug
11.7.4 Opioid Induced Constipation (OIC) Drug Product Description
11.7.5 Recent Development
11.8 Purdue Pharma
11.8.1 Purdue Pharma Company Details
11.8.2 Company Description
11.8.3 Sales, Revenue and Gross Margin of Opioid Induced Constipation (OIC) Drug
11.8.4 Opioid Induced Constipation (OIC) Drug Product Description
11.8.5 Recent Development
11.9 S.L.A. Pharma
11.9.1 S.L.A. Pharma Company Details
11.9.2 Company Description
11.9.3 Sales, Revenue and Gross Margin of Opioid Induced Constipation (OIC) Drug
11.9.4 Opioid Induced Constipation (OIC) Drug Product Description
11.9.5 Recent Development
11.10 Mundipharma International Limited
11.10.1 Mundipharma International Limited Company Details
11.10.2 Company Description
11.10.3 Sales, Revenue and Gross Margin of Opioid Induced Constipation (OIC) Drug
11.10.4 Opioid Induced Constipation (OIC) Drug Product Description
11.10.5 Recent Development
11.11 Ono Pharmaceutical
11.12 Takeda Pharmaceutical Company Limited
11.13 Theravance Biopharma
11.14 Valeant Pharmaceuticals International
11.15 Cosmo Pharmaceuticals SA
11.16 Daewoong Pharmaceutical
11.17 C.B. Fleet Company
11.18 Sucampo Pharmaceuticals
12 Market Opportunities, Challenges, Risks and Influences Factors Analysis
12.1 Market Opportunities and Drivers
12.2 Market Challenges
12.3 Market Risks/Restraints
12.4 Key World Economic Indicators
13 Value Chain and Sales Channels Analysis
13.1 Value Chain Analysis
13.1.1 Typical Suppliers of Key Opioid Induced Constipation (OIC) Drug Raw Material
13.1.2 Opioid Induced Constipation (OIC) Drug Customers
13.2 Sales Channels Analysis
13.2.1 Sales Channels Analysis
13.2.2 Distributors
14 Research Findings and Conclusion
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
15.3 Disclaimer
List of Tables and Figures
Figure Picture of Opioid Induced Constipation (OIC) Drug
Figure Global Opioid Induced Constipation (OIC) Drug Production (K Units) and CAGR (%) Comparison by Types (Product Category) (2013-2025)
Figure Global Opioid Induced Constipation (OIC) Drug Production Market Share by Types (Product Category) in 2017
Figure Lubiprostone Product Picture
Table Major Manufacturers of Lubiprostone
Figure Methyl Naltrexone Bromide Product Picture
Table Major Manufacturers of Methyl Naltrexone Bromide
Figure Naldemedine Product Picture
Table Major Manufacturers of Naldemedine
Figure Alvimopan Product Picture
Table Major Manufacturers of Alvimopan
Figure Other Product Picture
Table Major Manufacturers of Other
Table Global Opioid Induced Constipation (OIC) Drug Market Size Growth Rate by Application 2018-2025 (K Units)
Figure Hospital Pharmacies
Figure Retail Pharmacies
Figure Online Pharmacies
Figure Opioid Induced Constipation (OIC) Drug Report Years Considered
Figure Global Opioid Induced Constipation (OIC) Drug Market Size 2016-2025 (Million US$)
Figure Global Opioid Induced Constipation (OIC) Drug Sales 2016-2025 (K Units)
Table Global Opioid Induced Constipation (OIC) Drug Market Size by Regions 2016-2025 (K Units) & (Million US$)
Table Global Opioid Induced Constipation (OIC) Drug Sales by Regions 2016-2025 (K Units)
Table Global Opioid Induced Constipation (OIC) Drug Sales Market Share by Regions 2016-2025
Figure Global Opioid Induced Constipation (OIC) Drug Sales Market Share by Regions 2016-2025
Figure 2017 Global Opioid Induced Constipation (OIC) Drug Sales Market Share by Regions
Table Global Opioid Induced Constipation (OIC) Drug Revenue by Regions 2016-2025 (Million US$)
Table Global Opioid Induced Constipation (OIC) Drug Revenue Market Share by Regions 2016-2025
Figure Global Opioid Induced Constipation (OIC) Drug Revenue Market Share by Regions 2016-2025
Figure 2017 Global Opioid Induced Constipation (OIC) Drug Revenue Market Share by Regions
Table Global Opioid Induced Constipation (OIC) Drug Sales by Manufacturers (2016-2018) (K Units)
Table Global Opioid Induced Constipation (OIC) Drug Sales Share by Manufacturers (2016-2018)
Figure Global Opioid Induced Constipation (OIC) Drug Sales Share by Manufacturers in 2017
Table Opioid Induced Constipation (OIC) Drug Revenue by Manufacturers (2016-2018) (Million US$)
Table Opioid Induced Constipation (OIC) Drug Revenue Share by Manufacturers (2016-2018)
Figure Opioid Induced Constipation (OIC) Drug Value Share by Manufacturers in 2017
Table Global Opioid Induced Constipation (OIC) Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Manufacturers Opioid Induced Constipation (OIC) Drug Price (2016-2018) (USD/Unit)
Table Opioid Induced Constipation (OIC) Drug Manufacturers Manufacturing Base Distribution and Headquarters
Table Manufacturers Opioid Induced Constipation (OIC) Drug Product Category
Table Date of International Manufacturers Enter into Opioid Induced Constipation (OIC) Drug Market
Table Manufacturers Mergers & Acquisitions, Expansion Plans
Table Global Opioid Induced Constipation (OIC) Drug Sales by Type (2016-2025) (K Units)
Table Global Opioid Induced Constipation (OIC) Drug Sales Share by Type (2016-2025)
Figure Global Opioid Induced Constipation (OIC) Drug Sales Market Share by Type (2016-2025)
Figure Global Opioid Induced Constipation (OIC) Drug Sales Market Share by Type in 2017
Table Global Opioid Induced Constipation (OIC) Drug Revenue by Type (2016-2025) (Million US$)
Table Global Opioid Induced Constipation (OIC) Drug Revenue Share by Type (2016-2025)
Figure Global Opioid Induced Constipation (OIC) Drug Revenue Market Share by Type (2016-2025)
Figure Global Opioid Induced Constipation (OIC) Drug Revenue Market Share by Type in 2017
Table Opioid Induced Constipation (OIC) Drug Price by Type 2013-2018 (USD/Unit)
Table Global Opioid Induced Constipation (OIC) Drug Sales by Application (2016-2025) (K Units)
Table Global Opioid Induced Constipation (OIC) Drug Sales Share by Application (2016-2025)
Figure Global Sales Opioid Induced Constipation (OIC) Drug Market Share by Application (2016-2025)
Figure Global Sales Opioid Induced Constipation (OIC) Drug Market Share by Application (2016-2025)
Figure North America Opioid Induced Constipation (OIC) Drug Sales Growth Rate 2016-2025 (K Units)
Figure North America Opioid Induced Constipation (OIC) Drug Revenue Growth Rate 2016-2025 (Million US$)
Table North America Opioid Induced Constipation (OIC) Drug Sales by Countries (2016-2025) (K Units)
Table North America Opioid Induced Constipation (OIC) Drug Sales Market Share by Countries (2016-2025)
Figure 2017 North America Opioid Induced Constipation (OIC) Drug Sales Market Share by Countries
Table North America Opioid Induced Constipation (OIC) Drug Revenue by Countries (2016-2025) (Million US$)
Table North America Opioid Induced Constipation (OIC) Drug Revenue Market Share by Countries (2016-2025)
Figure 2017 North America Opioid Induced Constipation (OIC) Drug Revenue Market Share by Countries
Figure United States Opioid Induced Constipation (OIC) Drug Sales Growth Rate (2016-2025) (K Units)
Figure United States Opioid Induced Constipation (OIC) Drug Revenue Growth Rate (2016-2025) (Million US$)
Figure Canada Opioid Induced Constipation (OIC) Drug Sales Growth Rate (2016-2025) (K Units)
Figure Canada Opioid Induced Constipation (OIC) Drug Revenue Growth Rate (2016-2025) (Million US$)
Figure Mexico Opioid Induced Constipation (OIC) Drug Sales Growth Rate (2016-2025) (K Units)
Figure Mexico Opioid Induced Constipation (OIC) Drug Revenue Growth Rate (2016-2025) (Million US$)
Table North America Opioid Induced Constipation (OIC) Drug Sales by Type (2016-2025) (K Units)
Table North America Opioid Induced Constipation (OIC) Drug Sales Market Share by Type (2016-2025)
Figure 2017 North America Opioid Induced Constipation (OIC) Drug Market Share by Type
Table North America Opioid Induced Constipation (OIC) Drug Sales by Application (2016-2025) (K Units)
Table North America Opioid Induced Constipation (OIC) Drug Sales Market Share by Application (2016-2025)
Figure 2017 North America Opioid Induced Constipation (OIC) Drug Market Share by Application
Table North America Opioid Induced Constipation (OIC) Drug Sales by Company (2016-2018) (K Units)
Table North America Opioid Induced Constipation (OIC) Drug Sales Market Share by Company (2016-2018)
Figure North America Opioid Induced Constipation (OIC) Drug Sales Market Share by Company in 2017
Figure Europe Opioid Induced Constipation (OIC) Drug Sales Growth Rate 2016-2025 (K Units)
Figure Europe Opioid Induced Constipation (OIC) Drug Revenue Growth Rate 2016-2025 (Million US$)
Table Europe Opioid Induced Constipation (OIC) Drug Sales by Countries (2016-2025) (K Units)
Table Europe Opioid Induced Constipation (OIC) Drug Sales Market Share by Countries (2016-2025)
Figure 2017 Europe Opioid Induced Constipation (OIC) Drug Sales Market Share by Countries
Table Europe Opioid Induced Constipation (OIC) Drug Revenue by Countries (2016-2025) (Million US$)
Table Europe Opioid Induced Constipation (OIC) Drug Revenue Market Share by Countries (2016-2025)
Figure 2017 Europe Opioid Induced Constipation (OIC) Drug Revenue Market Share by Countries
Figure Germany Opioid Induced Constipation (OIC) Drug Sales Growth Rate (2016-2025) (K Units)
Figure Germany Opioid Induced Constipation (OIC) Drug Revenue Growth Rate (2016-2025) (K Units)
Figure France Opioid Induced Constipation (OIC) Drug Sales Growth Rate (2016-2025) (K Units)
Figure France Opioid Induced Constipation (OIC) Drug Revenue Growth Rate (2016-2025) (K Units)
Figure UK Opioid Induced Constipation (OIC) Drug Sales Growth Rate (2016-2025) (K Units)
Figure UK Opioid Induced Constipation (OIC) Drug Revenue Growth Rate (2016-2025) (Million US$)
Figure Italy Opioid Induced Constipation (OIC) Drug Sales Growth Rate (2016-2025) (K Units)
Figure Italy Opioid Induced Constipation (OIC) Drug Revenue Growth Rate (2016-2025) (Million US$)
Figure Russia Opioid Induced Constipation (OIC) Drug Sales Growth Rate (2016-2025) (K Units)
Figure Russia Opioid Induced Constipation (OIC) Drug Revenue Growth Rate (2016-2025) (Million US$)
Table Europe Opioid Induced Constipation (OIC) Drug Sales by Type (2016-2025) (K Units)
Table Europe Opioid Induced Constipation (OIC) Drug Sales Market Share by Type (2016-2025)
Figure 2017 Europe Opioid Induced Constipation (OIC) Drug Market Share by Type
Table Europe Opioid Induced Constipation (OIC) Drug Sales by Application (2016-2025) (K Units)
Table Europe Opioid Induced Constipation (OIC) Drug Sales Market Share by Application (2016-2025)
Figure 2017 Europe Opioid Induced Constipation (OIC) Drug Market Share by Application
Table Europe Opioid Induced Constipation (OIC) Drug Sales by Company (2016-2018) (K Units)
Table Europe Opioid Induced Constipation (OIC) Drug Sales Market Share by Company (2016-2018)
Figure Europe Opioid Induced Constipation (OIC) Drug Sales Market Share by Company in 2017
Figure Asia Pacific Opioid Induced Constipation (OIC) Drug Sales Growth Rate 2016-2025 (K Units)
Figure Asia Pacific Opioid Induced Constipation (OIC) Drug Revenue Growth Rate 2016-2025 (Million US$)
Table Asia Pacific Opioid Induced Constipation (OIC) Drug Sales by Countries (2016-2025) (K Units)
Table Asia Pacific Opioid Induced Constipation (OIC) Drug Sales Market Share by Countries (2016-2025)
Figure 2017 Asia Pacific Opioid Induced Constipation (OIC) Drug Sales Market Share by Countries
Table Asia Pacific Opioid Induced Constipation (OIC) Drug Revenue by Countries (2016-2025) (Million US$)
Table Asia Pacific Opioid Induced Constipation (OIC) Drug Revenue Market Share by Countries (2016-2025)
Figure 2017 Asia Pacific Opioid Induced Constipation (OIC) Drug Revenue Market Share by Countries
Figure China Opioid Induced Constipation (OIC) Drug Sales Growth Rate (2016-2025) (K Units)
Figure China Opioid Induced Constipation (OIC) Drug Revenue Growth Rate (2016-2025) (Million US$)
Figure Japan Opioid Induced Constipation (OIC) Drug Sales Growth Rate (2016-2025) (K Units)
Figure Japan Opioid Induced Constipation (OIC) Drug Revenue Growth Rate (2016-2025) (Million US$)
Figure Korea Opioid Induced Constipation (OIC) Drug Sales Growth Rate (2016-2025) (K Units)
Figure Korea Opioid Induced Constipation (OIC) Drug Revenue Growth Rate (2016-2025) (Million US$)
Figure India Opioid Induced Constipation (OIC) Drug Sales Growth Rate (2016-2025) (K Units)
Figure India Opioid Induced Constipation (OIC) Drug Revenue Growth Rate (2016-2025) (Million US$)
Figure Australia Opioid Induced Constipation (OIC) Drug Sales Growth Rate (2016-2025) (K Units)
Figure Australia Opioid Induced Constipation (OIC) Drug Revenue Growth Rate (2016-2025) (Million US$)
Figure Indonesia Opioid Induced Constipation (OIC) Drug Sales Growth Rate (2016-2025) (K Units)
Figure Indonesia Opioid Induced Constipation (OIC) Drug Revenue Growth Rate (2016-2025) (Million US$)
Figure Malaysia Opioid Induced Constipation (OIC) Drug Sales Growth Rate (2016-2025) (K Units)
Figure Malaysia Opioid Induced Constipation (OIC) Drug Revenue Growth Rate (2016-2025) (Million US$)
Figure Philippines Opioid Induced Constipation (OIC) Drug Sales Growth Rate (2016-2025) (K Units)
Figure Philippines Opioid Induced Constipation (OIC) Drug Revenue Growth Rate (2016-2025) (Million US$)
Figure Thailand Opioid Induced Constipation (OIC) Drug Sales Growth Rate (2016-2025) (K Units)
Figure Thailand Opioid Induced Constipation (OIC) Drug Revenue Growth Rate (2016-2025) (Million US$)
Figure Vietnam Opioid Induced Constipation (OIC) Drug Sales Growth Rate (2016-2025) (K Units)
Figure Vietnam Opioid Induced Constipation (OIC) Drug Revenue Growth Rate (2016-2025) (Million US$)
Figure Singapore Opioid Induced Constipation (OIC) Drug Sales Growth Rate (2016-2025) (K Units)
Figure Singapore Opioid Induced Constipation (OIC) Drug Revenue Growth Rate (2016-2025) (Million US$)
Table Asia Pacific Opioid Induced Constipation (OIC) Drug Sales by Type (2016-2025) (K Units)
Table Asia Pacific Opioid Induced Constipation (OIC) Drug Sales Market Share by Type (2016-2025)
Figure 2017 Asia Pacific Opioid Induced Constipation (OIC) Drug Market Share by Type
Table Asia Pacific Opioid Induced Constipation (OIC) Drug Sales by Application (2016-2025) (K Units)
Table Asia Pacific Opioid Induced Constipation (OIC) Drug Sales Market Share by Application (2016-2025)
Figure 2017 Asia Pacific Opioid Induced Constipation (OIC) Drug Market Share by Application
Table Asia Pacific Opioid Induced Constipation (OIC) Drug Sales by Company (2016-2018) (K Units)
Table Asia Pacific Opioid Induced Constipation (OIC) Drug Sales Market Share by Company (2016-2018)
Figure Asia Pacific Opioid Induced Constipation (OIC) Drug Sales Market Share by Company in 2017
Figure Central & South America Opioid Induced Constipation (OIC) Drug Sales Growth Rate 2016-2025 (K Units)
Figure Central & South America Opioid Induced Constipation (OIC) Drug Revenue Growth Rate 2016-2025 (Million US$)
Table Central & South America Opioid Induced Constipation (OIC) Drug Sales by Countries (2016-2025) (K Units)
Table Central & South America Opioid Induced Constipation (OIC) Drug Sales Market Share by Countries (2016-2025)
Figure 2017 Central & South America Opioid Induced Constipation (OIC) Drug Sales Market Share by Countries
Table Central & South America Opioid Induced Constipation (OIC) Drug Revenue by Countries (2016-2025) (Million US$)
Table Central & South America Opioid Induced Constipation (OIC) Drug Revenue Market Share by Countries (2016-2025)
Figure 2017 Central & South America Opioid Induced Constipation (OIC) Drug Revenue Market Share by Countries
Figure Brazil Opioid Induced Constipation (OIC) Drug Sales Growth Rate (2016-2025) (K Units)
Figure Brazil Opioid Induced Constipation (OIC) Drug Revenue Growth Rate (2016-2025) (Million US$)
Figure Argentina Opioid Induced Constipation (OIC) Drug Sales Growth Rate (2016-2025) (K Units)
Figure Argentina Opioid Induced Constipation (OIC) Drug Revenue Growth Rate (2016-2025) (Million US$)
Table Central & South America Opioid Induced Constipation (OIC) Drug Sales by Type (2016-2025) (K Units)
Table Central & South America Opioid Induced Constipation (OIC) Drug Sales Market Share by Type (2016-2025)
Figure 2017 Central & South America Opioid Induced Constipation (OIC) Drug Market Share by Type
Table Central & South America Opioid Induced Constipation (OIC) Drug Sales by Application (2016-2025) (K Units)
Table Central & South America Opioid Induced Constipation (OIC) Drug Sales Market Share by Application (2016-2025)
Figure 2017 Central & South America Opioid Induced Constipation (OIC) Drug Market Share by Application
Table Central & South America Opioid Induced Constipation (OIC) Drug Sales by Company (2016-2018) (K Units)
Table Central & South America Opioid Induced Constipation (OIC) Drug Sales Market Share by Company (2016-2018)
Figure Central & South America Opioid Induced Constipation (OIC) Drug Sales Market Share by Company in 2017
Figure Middle East and Africa Opioid Induced Constipation (OIC) Drug Sales Growth Rate 2016-2025 (K Units)
Figure Middle East and Africa Opioid Induced Constipation (OIC) Drug Revenue Growth Rate 2016-2025 (Million US$)
Table Middle East and Africa Opioid Induced Constipation (OIC) Drug Sales by Countries (2016-2025) (K Units)
Table Middle East and Africa Opioid Induced Constipation (OIC) Drug Sales Market Share by Countries (2016-2025)
Figure 2017 Middle East and Africa Opioid Induced Constipation (OIC) Drug Sales Market Share by Countries
Table Middle East and Africa Opioid Induced Constipation (OIC) Drug Revenue by Countries (2016-2025) (Million US$)
Table Middle East and Africa Opioid Induced Constipation (OIC) Drug Revenue Market Share by Countries (2016-2025)
Figure 2017 Middle East and Africa Opioid Induced Constipation (OIC) Drug Revenue Market Share by Countries
Figure GCC Countries Opioid Induced Constipation (OIC) Drug Sales Growth Rate (2016-2025) (K Units)
Figure GCC Countries Opioid Induced Constipation (OIC) Drug Revenue Growth Rate (2016-2025) (Million US$)
Figure Turkey Opioid Induced Constipation (OIC) Drug Sales Growth Rate (2016-2025) (K Units)
Figure Turkey Opioid Induced Constipation (OIC) Drug Revenue Growth Rate (2016-2025) (Million US$)
Figure Egypt Opioid Induced Constipation (OIC) Drug Sales Growth Rate (2016-2025) (K Units)
Figure Egypt Opioid Induced Constipation (OIC) Drug Revenue Growth Rate (2016-2025) (Million US$)
Figure South Africa Opioid Induced Constipation (OIC) Drug Sales Growth Rate (2016-2025) (K Units)
Figure South Africa Opioid Induced Constipation (OIC) Drug Revenue Growth Rate (2016-2025) (Million US$)
Table Middle East and Africa Opioid Induced Constipation (OIC) Drug Sales by Type (2016-2025) (K Units)
Table Middle East and Africa Opioid Induced Constipation (OIC) Drug Sales Market Share by Type (2016-2025)
Figure 2017 Middle East and Africa Opioid Induced Constipation (OIC) Drug Market Share by Type
Table Middle East and Africa Opioid Induced Constipation (OIC) Drug Sales by Application (2016-2025) (K Units)
Table Middle East and Africa Opioid Induced Constipation (OIC) Drug Sales Market Share by Application (2016-2025)
Figure 2017 Middle East and Africa Opioid Induced Constipation (OIC) Drug Market Share by Application
Table Middle East and Africa Opioid Induced Constipation (OIC) Drug Sales by Company (2016-2018) (K Units)
Table Middle East and Africa Opioid Induced Constipation (OIC) Drug Sales Market Share by Company (2016-2018)
Figure Middle East and Africa Opioid Induced Constipation (OIC) Drug Sales Market Share by Company in 2017
Table Ironwood Pharmaceuticals Company Details
Table Ironwood Pharmaceuticals Opioid Induced Constipation (OIC) Drug Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Ironwood Pharmaceuticals Recent Development
Table Daiichi Sankyo Co Company Details
Table Daiichi Sankyo Co Opioid Induced Constipation (OIC) Drug Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Daiichi Sankyo Co Recent Development
Table Pfizer Company Details
Table Pfizer Opioid Induced Constipation (OIC) Drug Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Pfizer Recent Development
Table Progenics Pharmaceuticals Company Details
Table Progenics Pharmaceuticals Opioid Induced Constipation (OIC) Drug Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Progenics Pharmaceuticals Recent Development
Table Shionogi & Company Details
Table Shionogi & Opioid Induced Constipation (OIC) Drug Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Shionogi & Recent Development
Table Allergan Company Details
Table Allergan Opioid Induced Constipation (OIC) Drug Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Allergan Recent Development
Table Nektar Therapeutics Company Details
Table Nektar Therapeutics Opioid Induced Constipation (OIC) Drug Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Nektar Therapeutics Recent Development
Table Purdue Pharma Company Details
Table Purdue Pharma Opioid Induced Constipation (OIC) Drug Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Purdue Pharma Recent Development
Table S.L.A. Pharma Company Details
Table S.L.A. Pharma Opioid Induced Constipation (OIC) Drug Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table S.L.A. Pharma Recent Development
Table Mundipharma International Limited Company Details
Table Mundipharma International Limited Opioid Induced Constipation (OIC) Drug Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Mundipharma International Limited Recent Development
Table Ono Pharmaceutical Company Details
Table Takeda Pharmaceutical Company Limited Company Details
Table Theravance Biopharma Company Details
Table Valeant Pharmaceuticals International Company Details
Table Cosmo Pharmaceuticals SA Company Details
Table Daewoong Pharmaceutical Company Details
Table C.B. Fleet Company Company Details
Table Sucampo Pharmaceuticals Company Details
Figure GDP by Regions / Largest Economies Pie Chart in 2016
Figure G20 GDP Long-Term Forecast Total, Million US dollars, 2060
Figure G20 Gross Domestic Product (GDP)Total, US Dollars/Capita, 2016
Figure Saving Rate Total, % of GDP, 2015
Table Opioid Induced Constipation (OIC) Drug Value Chain
Table Typical Suppliers of Key Opioid Induced Constipation (OIC) Drug Raw Material
Table Opioid Induced Constipation (OIC) Drug Customers List
Table Opioid Induced Constipation (OIC) Drug Sales Channels
Table Opioid Induced Constipation (OIC) Drug Distributors List
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
  • Global Immunofluorescence Assays Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 15-Nov-2018        Price: US 3480 Onwards        Pages: 115
    Immunofluorescence is the specific antigen and antibody reaction where the antibodies are labeled with a fluorescent dye and the antigen-antibody complex is visualized using fluorescent (UV) microscope. Some of the commonly used fluorochromes include Acridine Orange, Lissamine, Rhodamine, and Calcofluor white. Various factors determine the type of immunofluorescence assay used such as time consumed, cost, complexity, flexibility, sensitivity, cross reactivity and many others. It is used in all d......
  • Global Hospital Injectable Drugs Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 15-Nov-2018        Price: US 3480 Onwards        Pages: 115
    Drug injection is a method of introducing a drug into the bloodstream via a hollow hypodermic needle and a syringe, which is pierced through the skin into the body. Injectable drugs bypasses first-pass metabolism in the liver, resulting in higher bioavailability and efficiency for many drugs (such as morphine or diacetylmorphine/heroin; roughly two-thirds of which is destroyed in the liver when consumed orally) than oral ingestion would, meaning users get a stronger (yet shorter-a......
  • Global HPMC Capsules Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 15-Nov-2018        Price: US 3480 Onwards        Pages: 121
    Hydroxypropyl methylcellulose (HPMC), also known as hypromellose, is produced through the synthetic alteration of the natural polymer cellulose and is considered safe for human consumption. Read more: http://www.digitaljournal.com/pr/3726329#ixzz5RQbXrzzQ Scope of the Report: The worldwide market for HPMC Capsules is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to......
  • Global Humin Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 15-Nov-2018        Price: US 3480 Onwards        Pages: 118
    Humic substances like humus, humate, fulvic acid, organic matter, and humin play a key role in soil fertility. Plants grown in soil having an adequate amount of humic substances are healthier, produce higher yields; and have superior nutritional quality. Humins are that part of humic substances that not soluble in acids (low pH) or alkalis (high pH). These are not soluble in water at any pH. Humins are macro organic substances as their molecular weights range from approximately 100,000 to 10,000......
  • Global Immune Health Supplements Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 15-Nov-2018        Price: US 3480 Onwards        Pages: 137
    Immune Health Supplements refer to the product which could improve human immune health. Scope of the Report: The worldwide market for Immune Health Supplements is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study. This report focuses on the Immune Health Supplements in global market, especially in North America, Europe and Asia-Pacific......
  • Global Immunoglobulins Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 15-Nov-2018        Price: US 3480 Onwards        Pages: 122
    Immunoglobulin's also called as antibodies are large Y-shaped protein produced by B-cell. These are the glycoprotein molecule produced by plasma cells in response to entry of foreign entity such as bacteria and viruses in the body. Production of antibodies is an important function of immune system. Antibodies use binding mechanism for neutralizing the activity of a foreign particle called as an antigen. Scope of the Report: The worldwide market for Immunoglobulins is expec......
  • Global Immunology Drug Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 15-Nov-2018        Price: US 3480 Onwards        Pages: 118
    The immune system is an assembly of structures and processes inside the body to protect against possibly damaging foreign bodies and diseases. It identifies various threats like bacteria, viruses, and parasites and distinguishes them from body's healthy tissues. When the immune system weakness and lose the capability to detect and destroy the abnormal cells or body attacks and damages its tissues lead to diseases like cancer and autoimmune diseases. Immunotherapy is a process which includes the ......
  • 2018-2023 United States Medicinal Mushroom Extracts Market Report (Status and Outlook)
    Published: 15-Nov-2018        Price: US 3360 Onwards        Pages: 86
    In 2017, the Medicinal Mushroom Extracts market size was xx million USD in United States, and it will be xx million USD in 2023, with a CAGR of xx% between 2017 and 2023. In United States market, the top players include - Verygrass - Amino Up Chemical - Nammex - Baikal Herbs Ltd. - Johncan international - Aloha Medicinals - Limonnik - Fungi Perfecti - Kangxin - Shaanxi Undersun Biomedtech - GanoHerb......
  • 2018-2023 United States Sexual Enhancement Supplements Market Report (Status and Outlook)
    Published: 15-Nov-2018        Price: US 3360 Onwards        Pages: 89
    In 2017, the Sexual Enhancement Supplements market size was xx million USD in United States, and it will be xx million USD in 2023, with a CAGR of xx% between 2017 and 2023. In United States market, the top players include - Leading Edge Health - Innovus Pharmaceuticals - Direct Digital - SizeGenix - Vimax - Xanogen - Vydox - TEK Naturals Split by product types/category, covering - Male Sexual Enhancemen......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs